Back
Perspective Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CATX
Perspective Therapeutics
Last Price:
$4.1100
Seasonality Move:
8730.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Buy |
| 20-day SMA: | 3.71 | Buy |
| 50-day SMA: | 3.13 | Buy |
| 200-day SMA: | 4.73 | Sell |
| 8-day EMA: | 3.89 | Buy |
| 20-day EMA: | 3.68 | Buy |
| 50-day EMA: | 3.3 | Buy |
| 200-day EMA: | 4.71 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 61.61 | Buy |
| Chaikin Money Flow: | 449459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.3568 - 3.9168) | Buy |
| Bollinger Bands (100): | (2.1201 - 3.3401) | Buy |
Perspective Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 4.0800 while CATX 8-day simple moving average is 3.8575, which is a Buy signal.
-
The stock price of CATX is 4.0800 while Perspective Therapeutics 20-day SMA is 3.7105, which makes it a Buy.
-
Perspective Therapeutics 50-day simple moving average is 3.1284 while CATX share price is 4.0800, making it a Buy technically.
-
CATX stock price is 4.0800 and Perspective Therapeutics 200-day simple moving average is 4.7284, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Buy
56
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a BuyThe current Perspective Therapeutics [CATX] share price is $4.0800. The Score for CATX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
302.9M
Price in USD:
4.0800
Share Volume:
764.1K
Perspective Therapeutics 52-Week Range
52-Week High:
16.5500
52-Week Low:
1.6000
Buy
56
Perspective Therapeutics (CATX)
is a Buy
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 4.0800 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is not overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 4.0800 while CATX 8-day exponential moving average is 3.8897, which is a Buy signal.
-
The stock price of CATX is 4.0800 while Perspective Therapeutics 20-day EMA is 3.6785, which makes it a Buy.
-
Perspective Therapeutics 50-day exponential moving average is 3.2966 while CATX share price is 4.0800, making it a Buy technically.
-
CATX stock price is 4.0800 and Perspective Therapeutics 200-day simple moving average is 4.7059, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting Perspective Therapeutics is a Buy
-
Perspective Therapeutics Relative Strength Index (RSI) is 61.61, which suggest Perspective Therapeutics is overbought
-
The Bollinger Bands (25) for Perspective Therapeutics is (3.3568 - 3.9168), which suggest Perspective Therapeutics is a Buy
-
The Bollinger Bands (100) for Perspective Therapeutics is (2.1201 - 3.3401), which suggest Perspective Therapeutics is a Buy
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.